Wells Fargo’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229 Sell
28
-21
-43% -$446 ﹤0.01% 6584
2026
Q1
$2.54K Sell
49
-60
-55% -$4.35K ﹤0.01% 6221
2025
Q4
$9.55K Buy
+109
New +$25.6K ﹤0.01% 5966

Other funds holding PMI

Wells Fargo's PMI Position: Q2 2026 in Review

Wells Fargo reduced its Picard Medical (PMI) stake by 43% in Q2 2026, selling an estimated $446 and leaving 28 shares worth $229. The position accounts for ﹤0.01% of the portfolio, ranked #6584.

Wells Fargo first reported a position in PMI in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.55K in Q4 2025. 40 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Wells Fargo held 28 shares of Picard Medical worth $229 as of Q2 2026.
  • Wells Fargo sold 21 Picard Medical shares in Q2 2026, an estimated $446.
  • Picard Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6584 holding.
  • Wells Fargo first reported a position in Picard Medical in Q4 2025 and has held it in 3 quarters since.
  • Wells Fargo's Picard Medical position peaked at $9.55K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.